Literature DB >> 29662283

Intrauterine Copper Device (CuT380A) as a Contraceptive Method in the Indian Context: Acceptability, Safety and Efficacy Depending on the Timing of Insertion.

Purnima Gupta1, Madhavi Mathur Gupta2, Rachna Sharma2.   

Abstract

BACKGROUND: Ideal time of Intrauterine copper device (IUCD) insertion either to space or limit births in Indian women should be known to check fertility effectively and safely. We therefore aimed to compare various IUCD related clinical factors to assess its acceptability, safety and efficacy in immediate postpartum vaginal insertion, intra-caesarean insertion, delayed postpartum insertion and interval insertion at a tertiary-care centre in India.
METHODS: It was a retrospective analysis of prospectively collected data from July 2013 to July 2014. Data was reviewed about maternal age, socioeconomic status, education, occupation and parity of a total of 1631 eligible mothers and was compared between postpartum group and interval group. Data about spontaneous expulsion rate of IUCD, proportion of patients not able to feel thread, reasons for removal and failure rate of IUCD up to a follow-up period of 6 months was also collected in these women and compared among immediate vaginal insertion, intra-caesarean insertion, delayed postpartum insertion and interval insertion.
RESULTS: Majority of women were between 20 and 35 years of age group, literate, multiparous, unemployed and belonged to middle/lower socio-economic strata in both postpartum and interval groups. Spontaneous expulsion rates were 1.84, 0.84, 2.83 and 1.63%; proportions of patients not able to feel thread were 3.07, 8.73, 4.45 and 1.63%; and removal rates were 7.99, 6.48, 7.69 and 3.47% in immediate vaginal, intra-caesarean, delayed postpartum and interval insertion groups, respectively. Failure was seen in only one case of delayed postpartum insertion.
CONCLUSION: IUCD was more acceptable among young, literate and multiparous women as a contraceptive method. Immediate postpartum period was the safest and most efficacious time for IUCD insertion with least expulsion rate, maximum continuation rate and no failure and, therefore, should be encouraged by adequate counseling of mothers.

Entities:  

Keywords:  Contraception; Interval; Intrauterine copper device; Postpartum

Year:  2017        PMID: 29662283      PMCID: PMC5895549          DOI: 10.1007/s13224-017-1079-z

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  7 in total

Review 1.  Immediate post-partum insertion of intrauterine devices.

Authors:  David A Grimes; Laureen M Lopez; Kenneth F Schulz; Huib Aam Van Vliet; Nancy L Stanwood
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

2.  Updating income ranges for Kuppuswamy's socio-economic status scale for the year 2014.

Authors:  Sukhvinder Singh Oberoi
Journal:  Indian J Public Health       Date:  2015 Apr-Jun

3.  Insertion of intrauterine contraceptive device at caesarean section.

Authors:  Shereen Zulfiqar Bhutta; Iffat Javed Butt; Khadeja Bano
Journal:  J Coll Physicians Surg Pak       Date:  2011-09       Impact factor: 0.711

4.  Clinical Outcome of Postplacental Copper T 380A Insertion in Women Delivering by Caesarean Section.

Authors:  Sunita Singal; Rekha Bharti; Rupali Dewan; Anjali Dabral; Achla Batra; Manjula Sharma; Pratima Mittal
Journal:  J Clin Diagn Res       Date:  2014-09-20

5.  A Cross Sectional Study on Acceptability and Safety of IUCD among Postpartum Mothers at Tertiary Care Hospital, Telangana.

Authors:  Sangeetha Jairaj; Sridhar Dayyala
Journal:  J Clin Diagn Res       Date:  2016-01-01

6.  Women's experience with postpartum intrauterine contraceptive device use in India.

Authors:  Somesh Kumar; Reena Sethi; Sudharsanam Balasubramaniam; Elaine Charurat; Kamlesh Lalchandani; Richard Semba; Bulbul Sood
Journal:  Reprod Health       Date:  2014-04-23       Impact factor: 3.223

7.  Acceptance rate, probability of follow-up, and expulsion of postpartum intrauterine contraceptive device offered at two primary health centers, North India.

Authors:  Shashi Kant; S Archana; Arvind Kumar Singh; Farhad Ahamed; Partha Haldar
Journal:  J Family Med Prim Care       Date:  2016 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.